China and the United States dominate the landscape, with China leading by deal count. By mid-2026, 10 of the 15 largest humanoid rounds globally went to Chinese startups . China also leads in production, with 10 robot models (38% of tracked robots), followed by the U.S. with 9 (35%)
.
| Rank | Company | Country | Total Funding |
|---|---|---|---|
| 1 | UBTECH Robotics | China | $2.3 billion |
| 2 | Figure AI | USA | $1.7 billion |
| 3 | NEURA Robotics | Germany | $1.6 billion |
| 4 | Galbot | China | $986 million |
| 5 | Apptronik | USA | $935 million |
| 6 | Boston Dynamics | USA | $880 million |
| 7 | Unitree Robotics | China | $843 million |
Tesla's Optimus program is tracked separately, with an estimated $20+ billion in dedicated capex (2025–2026) and an implied standalone valuation of $150 billion+ .
The largest single humanoid round of 2026 went to a European company:
Ant Group has aggressively entered the humanoid robotics space through its subsidiary Robbyant (formally Shanghai Ant Lingbo Technology Co., Ltd.). Established in December 2024 with RMB 100 million in registered capital, Robbyant is Ant Group's wholly owned embodied AI and robotics company .
Robbyant unveiled its first humanoid robot, the R1, in September 2025 — a wheeled humanoid priced at approximately $55,000, designed for hospitality, medical support, museums, and kitchens . In 2026, Robbyant released LingBot-VLA 2.0 (an open-source vision-language-action model, July 2026) and LingBot-VA 2.0 (the industry's first embodied-native video-action world model)
.
Ant Group has made 12 investments in humanoid robotics companies in 18 months, most recently leading a 500 million yuan (~$70 million) round for Zeroth Robotics . Robbyant positions itself as a direct competitor to Tesla's Optimus, leveraging Ant Group's AI and fintech ecosystem
.
Several ETFs now offer diversified exposure to humanoid robotics, ranging from pure-play humanoid funds to broader robotics and automation funds :
Analysts recommend KOID, BOTT, and HUMN for concentrated humanoid exposure, while BOTZ and ROBO offer broader robotics diversification .
Available search results do not provide sufficient evidence to detail specific 2026 U.S. regulatory actions directly targeting humanoid robotics. The broader context includes existing export controls on advanced AI and semiconductor technology (imposed by the Bureau of Industry and Security since October 2022 and expanded through 2024–2025) that affect the chips and AI models used in humanoid robots, especially for Chinese companies. Ongoing CFIUS reviews of foreign investments in U.S. robotics and AI startups also apply. Proposed bills in Congress around AI safety, embodied AI liability, and national security reviews of advanced robotics have been discussed, but no specific finalized humanoid-focused regulation was captured in the available search results.
Note: The U.S. export control framework for advanced semiconductors, which power humanoid robots, continues to tighten. Any new specific 2026 actions targeting humanoid robotics hardware or software would require a dedicated search to confirm.